Quality of Life in Patients with Treatment-Resistant Depression Treated with Intranasal Esketamine as Add-On Therapy to an SSRI—A Prospective, Comparative Study in Real-World Clinical Practice
Szawarnoga D, Fojcik J, Górski M, Krzystanek M
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- pmc:PMC13708465
- Published
- Oct 1, 2026
- Venue
- Pharmaceuticals (Basel, Switzerland)
- PMC
- PMC13708465
- License
- CC-BY
- Provenance
- europepmc